NGM Biopharmaceuticals, Inc. (NGM) Financials

NGM Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 168.9 million 20.2 million
2023-09-30 192.2 million 22.3 million
2023-06-30 220.5 million 28.4 million
2023-03-31 258.8 million 37.9 million

NGM Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -23.2 million 6.3 million
2023-09-30 -27.5 million 6.4 million
2023-06-30 -40.4 million 7.5 million
2023-03-31 -42.5 million 8.5 million

NGM Net Income

No data available :(

NGM Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 147.2 million - -
2023-09-30 166.0 million - 1.4 million
2023-06-30 193.5 million - 2.8 million
2023-03-31 231.0 million - 4.1 million

NGM Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 82.8 million
2023-09-30 82.7 million
2023-06-30 82.5 million
2023-03-31 82.0 million

NGM Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 188000 21.4 million 7.9 million -
2023-09-30 290000 22.9 million 8.7 million -
2023-06-30 104000 32.4 million 9.6 million -
2023-03-31 670000 40.9 million 11.6 million -

NGM Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 165000 518000
2023-09-30 582000 500000
2023-06-30 1.4 million 1.1 million
2023-03-31 2.2 million 1.1 million

NGM

Price: $1.54

52 week price:
0.60
4.69

Earnings Per Share: -1.73 USD

P/E Ratio: -0.83

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 175000

Market Capitalization: 128.5 million

Links: